This is a news story, published by ABC News, that relates primarily to Cobenfy news.
For more Cobenfy news, you can click here:
more Cobenfy newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from ABC News, you can click here:
more news from ABC NewsOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
new schizophrenia drug. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest other schizophrenia drugs news, schizophrenia drug studies news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
promising schizophrenia drugABC News
•
80% Informative
Cobenfy 's main ingredient, xanomeline, works on a different receptor that indirectly blocks dopamine release in the brain.
The most common side effects of the drug are nausea, vomiting and indigestion.
Some participants said the drug reduced the voices while others said it didn't work for them.
The estimated yearly cost is $ 22,500 compared to $ 540 for a generic antipsychotic.
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group . The AP is solely responsible for all content..
VR Score
87
Informative language
91
Neutral language
28
Article tone
semi-formal
Language
English
Language complexity
48
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
1
Source diversity
1
Affiliate links
no affiliate links